Promethera's Cell Therapy Attracts Corporate VCs To Largest European Biopharma Funding Round This Year
This article was originally published in The Pink Sheet Daily
Executive Summary
Belgium's Promethera raises $31.4 million to start clinical trials of its cell therapy for orphan liver diseases in a Series B funding